MARYLEBONE HEALTH TECHNOLOGIES LTDActive

Company number 12417606Private limited companyIncorporated 2020

Key figures

£121,748-24.1%
Net assets 2024/25
+6.3%
Average annual growth 2020/21–2024/25
0200 k400 k600 k2020/212021/222022/232023/242024/25

Like most small UK companies, MARYLEBONE HEALTH TECHNOLOGIES LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0200 k400 k600 k2020/212021/222022/232023/242024/25
Filed accounts2020/21–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand———1,9253,164
Total assets178,525113,719451,18574,66111,665
Total liabilities83,18746,745121,55593,41842,268
Net assets / total equity95,33866,974414,588160,474121,748
Average number of employees33000

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: MARYLEBONE HEALTH TECHNOLOGIES LTD

Company

MARYLEBONE HEALTH TECHNOLOGIES LTD is a private limited company registered with Companies House under company number 12417606. It was incorporated on 21 Jan 2020. Its status is active. The registered office is in London (W1G). Its nature of business (SIC 2007) is general medical practice activities (86210), hairdressing and other beauty treatment (96020).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files abridged accounts (unaudited). Net assets were £121,748, down 24.1% on the previous year. Cash at bank and in hand was £3,164. Total assets were £11,665 and total liabilities £42,268. The company had an average of 0 employees. Figures are available for 5 financial years (2020/21–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 3 Feb 2027.